06.12.2023 - SAN FRANCISCO, CA / ACCESSWIRE / December 6, 2023 / Napo Pharmaceuticals (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) family company, today announced that the abstract for More Than a Diagnosis: A Quality of Life Survey for Individuals with a . Seite 1
04.12.2023 - Canalevia-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDACrofelemer, Jaguar s novel, oral plant-based drug sustainably harvested from the Croton lechleri tree, is the . Seite 1